Hormonal replacement therapy in an animal model with chronic renal failure and ovariectomy: Biochemical and densitometric study

Kidney International, Supplement

Volumn 63, Issue 85, 2003, Pages

  Rodriguez Rodriguez A ^b   Naves, M ^b   Rodriguez Rebollar A ^b   Gomez C ^b   Braga, S ^b   Cannata Andía, Jorge B ^a  

^a Serv de Metabolismo Oseo y Mineral   (Spain)

^b NONE

Author keywords

Bone mass; Estrogens calcitriol

Indexed keywords

CALCITRIOL; CALCIUM; ESTRADIOL; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE DENSITY; BONE DISEASE; BONE MASS; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CHEMICAL ANALYSIS; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFICACY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; LUMBAR SPINE; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RAT; TIBIA; TREATMENT OUTCOME; UTERUS WEIGHT;

EID: 0038187806     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s85.14.x     Document Type: Conference Paper

References (29)

1. COUTTENYE MM, D'HAESE PC, VERSCHOREN WJ, et al: Low bone turnover in patients with renal failure. Kidney Int (Suppl 73):S70-76, 1999
2. LOCATELLI F, CANNATA-ANDIA JB, DRUEKE TB, et al: Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant 17:723-731, 2002
3. SLATOPOLSKY E: The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism. Nephrol Dial Transplant 13(Suppl 3):3-8, 1998
4. SLATOPOLSKY E, BROWN AJ: Vitamin d analogs for the treatment of secondary hyperparathyroidism. Blood Purif 20:109-112, 2002
5. ANIS JA: Vitamin D analogs: From renal bone disease to osteoporosis. Kidney Int (Suppl 73):S77-81, 1999
6. CAULEY JA, ZMUDA JM, ENSRUD KE, et al: Timing of estrogen replacement therapy for optimal osteoporosis prevention. J Clin Endocrinol Metab 86:5700-5705, 2001
7. RIGGS BL, KHOSLA S, MELTON LJ 3RD: Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302, 2002
8. HOLLEY JL, SCHMIDT RJ: Hormone replacement therapy in postmenopausal women with end-stage renal disease: A review of the issues. Semin Dial 14:146-149, 2001
9. ORMROD D, MILLER T: Experimental uremia. Description of a model producing varying degrees of stable uremia. Nephron 26:249-254, 1980
10. WAYNFORTH H: Experimental and Surgical Technique in the Rat. London, Harcourt Brace Jovanovich, 1980
11. GOMEZ-ALONSO C, MENENDEZ-RODRIGUEZ P, VIRGOS-SORIANO MJ, et al: Aluminum-induced osteogenesis in osteopenic rats with normal renal function. Calcif Tissue Int 64:534-541, 1999
12. COBURN JW, ELANGOVAN L: Prevention of metabolic bone disease in the pre-end-stage renal disease setting. J Am Soc Nephrol 9:S71-77, 1998
13. TEN BOLSCHER M, NETELENBOS JC, BARTO R. et al: Estrogen regulation of intestinal calcium absorption in the intact and ovariectomized adult rat. J Bone Miner Res 14:1197-1202, 1999
14. LIEL Y, SHANY S, SMIRNOFF P, SCHWARTZ B: Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa. Endocrinology 140:280-285, 1999
15. VERHAEGHE J, OLOUMI G, VAN HERCK E, et al: Effects of long-term diabetes and/or high-dose 17 beta-estradiol on bone formation, bone mineral density, and strength in ovariectomized rats. Bone 20:421-428, 1997
16. STEPAN JJ, POSPICHAL J, PRESL J, PACOVSKY V: Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. Bone 8:279-284, 1987
17. KINNEY JH, HAUPT DL, BALOOCH M, et al: Three-dimensional morphometry of the L6 vertebra in the ovariectomized rat model of osteoporosis: Biomechanical implications. J Bone Miner Res 15:1981-1991, 2000
18. KALU DN: Evolution of the pathogenesis of postmenopausal bone loss. Bone 17:135S-144S, 1995
19. GISKE LE, HALL G, RUD T, LANDGREN BM: The effect of 17beta-estradiol at doses of 0.5, 1 and 2 mg compared with placebo on early postmenopausal bone loss in hysterectomized women. Osteoporos Int 13:309-316, 2002
20. YOSHIZAWA T, HANDA Y, UEMATSU Y, et al: Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16:391-396, 1997
21. JOHNSON JA, GRANDE JP, ROCHE PC, KUMAR R: Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues. Histochem Cell Biol 105:7-15, 1996
22. BRAIDMAN IP, HAINEY L, BATRA G, et al: Localization of estrogen receptor beta protein expression in adult human bone. J Bone Miner Res 16:214-220, 2001
23. KUSEC V, VIRDI AS, PRINCE R, TRIFFITT JT: Localization of estrogen receptor-alpha in human and rabbit skeletal tissues. J Clin Endocrinol Metab 83:2421-2428, 1998
24. LANGUB MC, REINHARDT TA, HORST RL, et al: Characterization of vitamin D receptor immunoreactivity in human bone cells. Bone 27:383-387, 2000
25. GALLAGHER JC, FOWLER SE, DETTER JR, SHERMAN SS: Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 86:3618-3628, 2001
26. KENEMANS P, VAN UNNIK GA, MIJATOVIC V, VAN DER MOOREN MJ: Perspectives in hormone replacement therapy. Maturitas 38 (Suppl 1):S41-48, 2001
27. MARPLE JT, MACDOUGALL M: Development of malignancy in the end-stage renal disease patient. Semin Nephrol 13:306-314, 1993
28. GINSBURG ES, OWEN WF, JR, GREENBERG LM, et al: Estrogen absorption and metabolism in postmenopausal women with end-stage renal disease. J Clin Endocrinol Metab 81:4414-4417, 1996
29. NAVES M, RODRÍGUEZ-RODRÍGUEZ A, DÍAz-CORTE C, et al: Effect of estrogen and calcitriol replacement in bone mass in rats with chronic renal failure and ovariectomy. Am J Soc Nephrol 12:746A, 2001